Varda Space is utilizing microgravity for pharmaceutical research [Yahoo! Finance Canada]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance Canada
Bruey outlines how microgravity works and how the company is utilizing it here on Earth: "It's ubiquitous and it's impossible to create in perpetuity on Earth. And so we essentially are building space manufacturing modules because we can change the outcome of chemical systems like no one else can on Earth." "In 2019, Merck ( MRK ) actually published a particularly interesting result where they actually took their blockbuster monoclonal antibody, Keytruda. It does $25 billion of revenue for them every year, financial analysts estimate that it represents about $125 billion of their market cap," Asparouhouv elaborates, adding: "They were able to show that... when you turn off gravity, the chemical system changes, and it changes in a very unexpected way. And the result of that change was And the result of that change was they actually found... a version of the drug up in space that, rather than having to be delivered the way that it is today via an intravenous drip, where you're goin
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients [Yahoo! Finance]Yahoo! Finance
- Roche's (RHHBY) Combo Therapy Misses Lung Cancer Study Goals [Yahoo! Finance]Yahoo! Finance
- Roche to Halt Lung Cancer Drug Study in Fresh Setback [BNN Bloomberg (Canada)]BNN Bloomberg
- Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly [Yahoo! Finance]Yahoo! Finance
- Evaxion Reinforces Milestone Timeline and Provides Shareholder Update [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 4/25/24 - Beat
MRK
Sec Filings
- 7/2/24 - Form 4
- 7/2/24 - Form 4
- 7/2/24 - Form 4
- MRK's page on the SEC website